IUPHAR review - Glucagon-like peptide-1 (GLP-1) and substance use disorders: an emerging pharmacotherapeutic target
What Should You Eat on a GLP-1
Injection & Handling Considerations Improper storage, mixing, or administration techniques may increase the risk of: Injection-site irritation Local inflammation Reduced peptide stability Reduced compound integrity Additional Research Notes Higher administration amounts do not necessarily produce proportionally greater effects and may increase the likelihood of side effects Gastrointestinal effects are among the most commonly observed responses in incretin-based metabolic research Individual responses may vary significantly depending on metabolic status, sensitivity, and concurrent research compounds For Research Use Only Not intended to diagnose, treat, cure, or prevent any disease
Were here for the customers and the community
Best for: dry, depleted skin, stressed-feeling skin, fine lines caused by dryness, loss of bounce, overnight recovery, and skin that needs the next level beyond basic moisture
